Sciences · Glossary
21 CFR Part 11
21 CFR Part 11 is the FDA regulation governing electronic records and electronic signatures in regulated life-science environments. It defines what makes a digital record trustworthy: audit trails, access controls, validation, and legally binding e-signatures.
For software sold into pharma, biotech, and clinical labs, Part 11 compliance is a gate: systems must be validated and must maintain tamper-evident audit trails and controlled signatures. It shapes how lab informatics, LIMS, and quality systems are built and implemented far more than feature lists do.
In practice
In day-to-day operations within the life sciences industry, 21 CFR Part 11 significantly impacts quality assurance teams, IT departments, and regulatory compliance officers. These professionals must ensure that electronic systems for data capture and signatures are compliant, which drives decisions around software selection, validation protocols, and data integrity measures. Compliance with this regulation is critical commercially, as it helps prevent costly penalties and product recalls while ensuring data is reliable for regulatory submissions and audits.
Where 21 CFR Part 11 shows up on MarketScale
What is MarketScale
MarketScale is a content platform that helps Sciences teams turn their expertise into articles, video, and audience. Want this kind of coverage for your work?
Free workspace
Turn your own experts into media like this.
You came for the ideas. You can publish them too. A free MarketScale workspace gives your team the tools to capture, produce, and distribute video, podcasts, and articles that buyers act on. No credit card, no demo required.
NPS +73 · 1,000+ creators · 38+ countries
What you get, free